Impact of coverage-dependent marginal costs on optimal HPV vaccination strategies.

dc.contributor.author

Ryser, MD

dc.contributor.author

McGoff, K

dc.contributor.author

Herzog, DP

dc.contributor.author

Sivakoff, DJ

dc.contributor.author

Myers, ER

dc.coverage.spatial

Netherlands

dc.date.accessioned

2015-03-11T20:37:28Z

dc.date.issued

2015-06

dc.description.abstract

The effectiveness of vaccinating males against the human papillomavirus (HPV) remains a controversial subject. Many existing studies conclude that increasing female coverage is more effective than diverting resources into male vaccination. Recently, several empirical studies on HPV immunization have been published, providing evidence of the fact that marginal vaccination costs increase with coverage. In this study, we use a stochastic agent-based modeling framework to revisit the male vaccination debate in light of these new findings. Within this framework, we assess the impact of coverage-dependent marginal costs of vaccine distribution on optimal immunization strategies against HPV. Focusing on the two scenarios of ongoing and new vaccination programs, we analyze different resource allocation policies and their effects on overall disease burden. Our results suggest that if the costs associated with vaccinating males are relatively close to those associated with vaccinating females, then coverage-dependent, increasing marginal costs may favor vaccination strategies that entail immunization of both genders. In particular, this study emphasizes the necessity for further empirical research on the nature of coverage-dependent vaccination costs.

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/25979280

dc.identifier

S1755-4365(15)00005-5

dc.identifier.eissn

1878-0067

dc.identifier.uri

https://hdl.handle.net/10161/9500

dc.language

eng

dc.publisher

Elsevier BV

dc.relation.ispartof

Epidemics

dc.relation.isversionof

10.1016/j.epidem.2015.01.003

dc.subject

Human papillomavirus vaccination

dc.subject

Male HPV vaccination

dc.subject

Marginal distribution costs

dc.subject

Optimal vaccine distribution

dc.subject

Stochastic agent-based models

dc.subject

Adolescent

dc.subject

Cohort Studies

dc.subject

Cost-Benefit Analysis

dc.subject

Female

dc.subject

Health Care Rationing

dc.subject

Human papillomavirus 16

dc.subject

Humans

dc.subject

Immunization Programs

dc.subject

Male

dc.subject

Papillomavirus Infections

dc.subject

Papillomavirus Vaccines

dc.title

Impact of coverage-dependent marginal costs on optimal HPV vaccination strategies.

dc.type

Journal article

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/25979280

pubs.begin-page

32

pubs.end-page

47

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Gynecology

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Obstetrics

pubs.organisational-group

Obstetrics and Gynecology

pubs.organisational-group

School of Medicine

pubs.organisational-group

Staff

pubs.publication-status

Published

pubs.volume

11

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ryser et al_Impact of coverage-dependent marginal costs on optimal HPV vaccination strategies.pdf
Size:
1.69 MB
Format:
Adobe Portable Document Format
Description:
Published version